124 related articles for article (PubMed ID: 38482975)
1. Low pH condition impairs BP-IgG binding to the basement membrane zone.
Im D; Ueda K; Niwa H; Tanaka K; Iwata H
J Dermatol; 2024 May; 51(5):643-648. PubMed ID: 38482975
[TBL] [Abstract][Full Text] [Related]
2. The predominance of IgG4 in prodromal bullous pemphigoid.
Lamb PM; Patton T; Deng JS
Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
[TBL] [Abstract][Full Text] [Related]
3. A predominant IgG4 subclass may be responsible for false-negative direct immunofluorescence in bullous pemphigoid.
Buschman KE; Seraly M; Thong HY; Deng JS; Draviam RP; Abernethy JL
J Cutan Pathol; 2002 May; 29(5):282-6. PubMed ID: 12100628
[TBL] [Abstract][Full Text] [Related]
4. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
Allen J; Shears E; Powell J; Wojnarowska F
Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
[TBL] [Abstract][Full Text] [Related]
5. IgA basement membrane zone autoantibodies in bullous pemphigoid detect epidermal antigens of 270-280 kDa, 230 kDa, and 180 kDa molecular weight by immunoblotting.
Kirtschig G; Wojnarowska F
Clin Exp Dermatol; 1999 Jul; 24(4):302-7. PubMed ID: 10457136
[TBL] [Abstract][Full Text] [Related]
6. [Subepidermal bullous autoimmune dermatosis with linear deposition of IgA amd IgG].
Kersting E; Goebeler M; Hamm H; Rose C; Zillikens D; Bröcker EB
Hautarzt; 2000 May; 51(5):340-4. PubMed ID: 10875072
[TBL] [Abstract][Full Text] [Related]
7. Differences in direct immunofluorescence staining patterns in epidermolysis bullosa acquisita and bullous pemphigoid.
Smoller BR; Woodley DT
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):674-8. PubMed ID: 1430385
[TBL] [Abstract][Full Text] [Related]
8. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
Suzuki M; Watanabe C; Yaoita H
Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
[TBL] [Abstract][Full Text] [Related]
9. Blister fluid for the diagnosis of subepidermal immunobullous diseases: a comparative study of basement membrane zone autoantibodies detected in blister fluid and serum.
Zhou S; Wakelin SH; Allen J; Wojnarowska F
Br J Dermatol; 1998 Jul; 139(1):27-32. PubMed ID: 9764145
[TBL] [Abstract][Full Text] [Related]
10. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
Gomes MA; Dambuyant C; Thivolet J; Bussy R
Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
[TBL] [Abstract][Full Text] [Related]
11. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
[TBL] [Abstract][Full Text] [Related]
12. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus.
Shirakata Y; Shiraishi S; Sayama K; Miki Y
J Dermatol; 1990 Nov; 17(11):661-6. PubMed ID: 2094743
[TBL] [Abstract][Full Text] [Related]
13. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.
Kamata A; Kurihara Y; Funakoshi T; Takahashi H; Kuroda K; Hachiya T; Amagai M; Yamagami J
Br J Dermatol; 2020 May; 182(5):1221-1227. PubMed ID: 31330562
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol/L salt-split skin. Specificity, sensitivity, and practical considerations.
Lazarova Z; Yancey KB
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):398-403. PubMed ID: 8784276
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactive idiotypes in the sera of patients with bullous pemphigoid express anti-basement-membrane-zone activity.
Rico MJ; Hall RP
Dermatology; 1994; 189 Suppl 1():72-5. PubMed ID: 7519488
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid.
Sárdy M; Kostaki D; Varga R; Peris K; Ruzicka T
J Am Acad Dermatol; 2013 Nov; 69(5):748-753. PubMed ID: 23969034
[TBL] [Abstract][Full Text] [Related]
18. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
19. False-Negative Rate of Direct Immunofluorescence on Lower Extremities in Bullous Pemphigoid.
Perry DM; Wilson A; Self S; Maize JC
Am J Dermatopathol; 2021 Jan; 43(1):42-44. PubMed ID: 32618708
[TBL] [Abstract][Full Text] [Related]
20. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]